Chen-he Yi - Publications

Tumor-Boundary Response Index (TBRI)- A promising indicator for predicting outcomes in colorectal liver metastases receiving neoadjuvant therapy: Insights from a single-center retrospective study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 15, 2025

The prognostic significance of histopathological growth patterns in liver metastases undergoing surgery: a systematic review and meta-analysis.

Journal: Clinical & experimental metastasis

Published: March 22, 2025

The Significance of CEA Levels Normalization After Neoadjuvant Therapy in Patients With Initially Resectable Colorectal Liver Metastases.

Journal: The Journal of surgical research

Published: December 27, 2024

GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers.

Journal: Clinical and molecular hepatology

Published: August 12, 2024

Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC.

Journal: Molecular and cellular biochemistry

Published: June 18, 2024

Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.

Journal: Journal for immunotherapy of cancer

Published: January 18, 2023

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8+ T-cell immune responses.

Journal: Cancer management and research

Published: October 17, 2018

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma.

Journal: OncoTargets and therapy

Published: May 03, 2018